why choose us

First received: July 15, 2026

Clinical Trial: Survival Outcomes of Residual Disease in Triple-Negative Breast Cancer

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Triple-Negative Breast Cancer (TNBC)

Study Type: OBSERVATIONAL


Official Title: Survival Outcomes of Residual Disease in Patients With Triple-Negative Breast Cancer Following Neoadjuvant Therapy: A Retrospective Cohort Study

Brief Summary: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer associated with a poor prognosis. Although neoadjuvant therapy improves outcomes in patients who achieve a pathological complete response, the presence of residual disease after treatment remains associated with an increased risk of recurrence and death. This retrospective cohort study aims to evaluate the survival outcomes of patients with residual disease following neoadjuvant therapy for TNBC and to assess the association between…

Read more